首页> 外国专利> METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE IN METABOLIC SYNDROME

METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE IN METABOLIC SYNDROME

机译:代谢综合征患者糖耐量减低的患者血管内皮功能障碍矫正方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to therapy and endocrinology, and concerns correction of endothelial dysfunction in patients with impaired glucose tolerance in metabolic syndrome. That is ensured by administering metformin with low-carbo hypocaloric diet. Metformin is administered for first 5 days in an initial dose of 500 mg/day with subsequent increase every 5 days/500 mg/day to a maximum dose of 2000 mg/day. That is combined with daily physical activity and one day of limited intake of food once a week. Treatment is performed for 3 months.;EFFECT: such empirically selected complex of drug-induced and drug-free therapy provides effective correction of endothelial dysfunction in the given group of patients.;3 cl, 1 tbl
机译:发明领域本发明涉及医学,即涉及治疗和内分泌学,涉及对代谢综合症的糖耐量低下的患者的内皮功能障碍的矫正。通过在低碳水化合物低热量饮食中服用二甲双胍可以确保这一点。二甲双胍的前5天以500 mg /天的初始剂量给药,随后每5天/ 500 mg /天增加一次,最大剂量为2000 mg /天。这与每天的体育锻炼和每天有限的一天的食物摄入量相结合。治疗进行了3个月。效果:这种根据经验选择的药物诱导和无药物治疗复合物可有效纠正给定患者组的内皮功能障碍; 3 cl,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号